Skip to main content
Equibles

Gordon G. Carmichael

Board Member

Gyre Therapeutics, Inc. (GYRE)

Equibles does not estimate personal net worth.

Get an email with a short summary when Gyre Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get GYRE alerts

About Gordon G. Carmichael

Gordon G. Carmichael is recorded as Board Member at Gyre Therapeutics, Inc. (GYRE) since October 30, 2023. Gyre Therapeutics, Inc. reported in an 8-K filed October 30, 2023 that Gordon G. Carmichael was appointed Class I Director, effective October 30, 2023. Gyre Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gyre Therapeutics, Inc. includes Charles Wu (CEO and Board Member), Dr. Han Ying (CEO), Dr. Ying Luo (CEO and Board Member) and 7 others.

“On October 30, 2023, the Board increased the authorized number of directors to be eight (8) members and appointed the following five (5) individuals to the Board: Gordon G. Carmichael, Ph.D. (as a Class I Director), Songjiang Ma (as a Class I Director), Renate Perry, Ph.D. (as a Class III Director), Charles Wu, Ph.D. (as a Class III Director) and Han Ying, Ph.D. (as a Class II Director) to the Board.”
Gyre Therapeutics, Inc. Form 8-K, filed October 30, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Gyre Therapeutics, Inc.

Recent activity